A High-Throughput Assay for Connexin 43 (Cx43,GJA1) Gap Junctions Using Codon-Optimized Aequorin
- 1 March 2013
- journal article
- research article
- Published by Mary Ann Liebert Inc in ASSAY and Drug Development Technologies
- Vol. 11 (2), 93-100
- https://doi.org/10.1089/adt.2012.469
Abstract
Gap junctions (GJs) are intercellular channels which are composed of the connexin family of proteins that allow electrical and chemical communications and synchronization in tissue ensembles. Evidence suggests that pharmaceutical modulators of these channels may have therapeutic potential or carry undesired liability. In this report, we exogenously expressed human connexin 43 (Cx43, GJA1) and demonstrated functionality in a 96-well flow cytometry assay detecting intercellular transfer of the calcein dye. We have designed a 384-well high-throughput method for detecting the transfer of calcium between HeLa cells expressing Cx43. In this assay, donor cells coexpress Cx43 and the α1A adrenergic Gα-coupled receptor, while recipient cells coexpress Cx43 and the cytoplasmic version of the calcium-sensitive luminescent protein aequorin enhanced by codon optimization (cytoAeq). The two cell populations were mixed, dispensed to 384-well plates, and incubated for 3 h to allow the formation of GJs. Activation of α1A by epinephrine in donor cells led to dose-dependent calcium increases in recipient cells, which were detected by measuring the intensity of aequorin luminescence. The response was dependent on the expression of Cx43 and inhibited by the GJ blocker 18α-glycyrrhetinic acid, suggesting Cx43 GJ-mediated activity. In a parallel experiment with capsaicin and the TrpV1 ion channel in place of phenylephrine and α1A, a similar magnitude of difference in the maximal calcium response was detected in both donor and recipient cells, suggesting that calcium is likely the permeant ion through the GJ. This assay may pave the way for high-throughput screening of GJ modulators for drug discovery.Keywords
This publication has 34 references indexed in Scilit:
- Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failureNature Biotechnology, 2012
- Pharmacological modulation of connexin‐formed channels in cardiac pathophysiologyBritish Journal of Pharmacology, 2011
- A novel mutation in the connexin 26 gene (GJB2) in a child with clinical and histological features of keratitis–ichthyosis–deafness (KID) syndromeClinical and Experimental Dermatology, 2011
- Assay for molecular transport across gap junction channels in one-dimensional cell arraysLab on a Chip, 2011
- Tonabersat, a Gap-Junction Modulator: Efficacy and Safety in Two Randomized, Placebo-Controlled, Dose-Ranging Studies of Acute MigrainecephCephalalgia, 2009
- A description of the structural determination procedures of a gap junction channel at 3.5 Å resolutionActa Crystallographica Section D-Structural Biology, 2009
- Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)13, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial FibrillationJournal of Medicinal Chemistry, 2009
- Connexin channel permeability to cytoplasmic moleculesProgress in Biophysics and Molecular Biology, 2007
- Life Cycle of Connexins: Regulation of Connexin Synthesis and DegradationAdvances in cardiology, 2006
- Calcium-mobilizing receptors, polyphosphoinositides, generation of second messengers and contraction in the mammalian iris smooth muscle: Historical perspectives and current statusLife Sciences, 1989